2/21/2012

Siemens has entered agreements with Tocagen and ViiV Healthcare to better position itself in the companion diagnostics arena. Siemens' deal with ViiV Healthcare covers a tropism assay for an already-approved HIV treatment, while its agreement with Tocagen involves creating a companion diagnostic test to support clinical studies of Tocagen's brain cancer treatment.

Related Summaries